z-logo
open-access-imgOpen Access
Prostaglandin E 2 promotes MYCN non‐amplified neuroblastoma cell survival via β‐catenin stabilization
Author(s) -
Jansen Sepp R.,
Holman Rian,
Hedemann Ilja,
Frankes Ewoud,
Elzinga Carolina R. S.,
Timens Wim,
Gosens Reinoud,
Bont Eveline S.,
Schmidt Martina
Publication year - 2015
Publication title -
journal of cellular and molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.44
H-Index - 130
eISSN - 1582-4934
pISSN - 1582-1838
DOI - 10.1111/jcmm.12418
Subject(s) - neuroblastoma , viability assay , forskolin , cancer research , biology , gsk 3 , ectopic expression , catenin , microbiology and biotechnology , wnt signaling pathway , signal transduction , cell , cell culture , biochemistry , genetics
Amplification of MYCN is the most well‐known prognostic marker of neuroblastoma risk classification, but still is only observed in 25% of cases. Recent evidence points to the cyclic adenosine monophosphate ( cAMP ) elevating ligand prostaglandin E 2 ( PGE 2 ) and β‐catenin as two novel players in neuroblastoma. Here, we aimed to define the potential role of PGE 2 and cAMP and its potential interplay with β‐catenin, both of which may converge on neuroblastoma cell behaviour. Gain and loss of β‐catenin function, PGE 2 , the adenylyl cyclase activator forskolin and pharmacological inhibition of cyclooxygenase‐2 ( COX ‐2) were studied in two human neuroblastoma cell lines without MYCN amplification. Our findings show that PGE 2 enhanced cell viability through the EP 4 receptor and cAMP elevation, whereas COX ‐2 inhibitors attenuated cell viability. Interestingly, PGE 2 and forskolin promoted glycogen synthase kinase 3β inhibition, β‐catenin phosphorylation at the protein kinase A target residue ser675, β‐catenin nuclear translocation and TCF ‐dependent gene transcription. Ectopic expression of a degradation‐resistant β‐catenin mutant enhances neuroblastoma cell viability and inhibition of β‐catenin with XAV 939 prevented PGE 2 ‐induced cell viability. Finally, we show increased β‐catenin expression in human high‐risk neuroblastoma tissue without MYCN amplification. Our data indicate that PGE 2 enhances neuroblastoma cell viability, a process which may involve cAMP ‐mediated β‐catenin stabilization, and suggest that this pathway is of relevance to high‐risk neuroblastoma without MYCN amplification.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here